Farhad Ravandi - Free People Check with News, Pictures & Links

	Texas Houston Anderson Los angeles Santa monica

	Oncology Professor Anderson Cancer Center University of Texas Ravandi Kashani Department of Leukemia Acute

Images of Farhad Ravandi

(1 - 4 from 4 )

News

(1 - 4 from 6

–show all

)

Alemtuzumab shows promise for T-cell large granular lymphocytic...

www.healio.com

A single treatment course of alemtuzumab appeared to produce a hematological response in patients with relapsed and refractory T-cell large granular...

Gene sequencing project identifies abnormal gene that launches rare...

www.stjude.org

St. Jude Children’s Research Hospital – Washington University Pediatric Cancer Genome Project discovery provides insight into a tough-to-cure form of acute...

Vosaroxin may improve outcomes for older patients with relapsed,...

www.healio.com

“The prognosis for patients with relapsed or refractory AML is poor; median survival is less than 1 year,” Farhad Ravandi, MD, professor of ...

Sunesis Announces Presentation of Positive Results From Ongoing MD...

baycitycapital.com

... many patients not tolerating or responding to existing therapies,” said Farhad Ravandi, M.D., Professor of Medicine, Department of Leukemia, ...

Telephone & Addresses

(1 - 4 from 6

–show all

)

Farhad Farhad Ravandi, Houston, US, Westheimer Rd, Apt 429

View Farhad's social profiles and photos on Facebook, MySpace, and +40 Networks.

Farhad Farhad Ravandi, Los Angeles, US, Westwood Blvd, Unit 159

View Farhad's social profiles and photos on Facebook, MySpace, and +40 Networks.

Farhad Farhad Ravandi, 55, Santa Monica, US, 30th St

View Farhad's social profiles and photos on Facebook, MySpace, and +40 Networks.

Farhad Ravandi, 51, …go, US, E Erie St, Apt 4013

View Farhad's social profiles and photos on Facebook, MySpace, and +40 Networks.

Physicians & MDs

Treatment Tracker - Farhad Ravandi-kashani

projects.propublica.org

CATEGORY. Description of Service, Times Performed (or Units), This Service's Rank, Patients, Unique Visits Per Patient, Billed to Medicare, Payments from ...

Network Profiles

(1 - 4 from 6

–show all

)

Facebook: Farhad Ravandi | Facebook

Facebook: Farhad Ravandi-Kashani - Houston, Texas - Oncologist | Facebook

Facebook: Congratulations to Dr. Farhad Ravandi MD Anderson Leukemia ...

LinkedIn: Farhad Ravandi - Australia | LinkedIn

View Farhad Ravandi's (Australia) professional profile on LinkedIn. LinkedIn is the world's largest business network, helping professionals like Farhad Ravandi ...

Interests

(1 - 4 from 6

–show all

)

Study shows improved survival in aggressive acute myeloid leukemia |...

www.eurekalert.org

Patients who relapse in their battle with acute myeloid leukemia may benefit from a phase three study of therapies that combine an existing agent, cytarabine,...

Sunesis Spin Doctor Tiptoes Around Failed Leukemia Drug Trial - Stock...

www.thestreet.com

Sunesis' experimental leukemia drug vosaroxin underwent a miraculous transformation during a Sunday morning press briefing at the American Society of...

Tangle in AML: Is VALOR 'Crummy' or the 'New Standard'?

www.medscape.com

A phase 3 study of relapsed and treatment-resistant AML was interpreted differently by a pair of academics.

Farhad Ravandi - Patents

www.freshpatents.com

Farhad Ravandi patents Recent bibliographic sampling of Farhad Ravandi patents listed/published in the public domain by the USPTO (USPTO Patent Application #,Title):

Business Profiles

patentbuddy: Farhad Ravandi

THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS, Houston, TX, US

Private Homepages

Please refer to here - Peng Qiu

pengqiu.gatech.edu

Christopher B Benton, Farhad Ravandi, Michael Andreeff, Tapan Kadia, Vivian Ruvolo, Peng Qiu, David A Wheeler, Guillermo Garcia-Manero, Jorge Cortes, ...

Education

www.columbia.edu

Alfonso Quintás-Cardama, Jorge E. Cortes, Susan O'Brien, Farhad Ravandi, Gautam Borthakur, David Liu, Eric Bleickardt, Tai-Tsang Chen, Hagop M. Kantarjian.

Books & Literature

(1 - 4 from 19

–show all

)

Farhad Ravandi, MD

www.managingaml.com

Dr. Farhad Ravandi received his medical degree from St. Mary's Hospital Medical School/Imperial College, University of London. He completed clinical ...

Farhad Ravandi, MD. Jul 12, In their scholarly article, Dr. Park and Dr. Tallman review the important clinical trials for treating patients with APL reported over the last two decades and argue the case for further reduction and perhaps elimination of conventional cytotoxic chemotherapy in the frontline treatment of this ...

undefined

www.psychiatrictimes.com

By Farhad Ravandi, MD. In their scholarly article, Dr. Park and Dr. Tallman review the important clinical trials for treating patients with APL ...

Chronic Myeloid Neoplasias and Clonal Overlap Syndromes: Epidemiology...

books.google.nl

Introduction The understanding of the genetic, epigenetic, immuno- well as for practicing hematologists or oncologists. logical and biological causes of...

Scientific Publications

(1 - 4 from 11

–show all

)

Clinical Lymphoma Myeloma and Leukemia | Vol 13, Issue 4, Pages...

www.sciencedirect.com

The online version of Clinical Lymphoma Myeloma and Leukemia at ScienceDirect.com, the world's leading platform for high quality peer-reviewed full-text...

Long-Term Follow-up of Phase II Study of Chemotherapy Plus Dasatinib...

www.ncbi.nlm.nih.gov

Farhad Ravandi,1 Susan O'Brien,1 Jorge Cortes,1 Deborah Thomas,1 Rebecca Garris,1 Stefan Faderl,1 Jan Burger,1 Michael Rytting,1 Alessandra Ferrajoli,1 William Wierda,1 Srdan Verstovsek,1 Richard Champlin,2 Partow Kebriaei,2 Deborah McCue,3 Xuelin Huang,4 Elias Jabbour,1 Guillermo ...

MLL gene amplification in acute myeloid leukemia and myelodysplastic...

www.sciencedirect.com

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX , USA. , MD. ,. Farhad Ravandi. x. Farhad Ravandi.

Feasibility of Therapy With Hypomethylating Agents in Patients With...

www.ncbi.nlm.nih.gov

Farhad Ravandi, Hagop Kantarjian, Jean-Pierre J. Issa, Guillermo Garcia-Manero, and Jorge E. Cortes have received research funding from Eisai Inc. Farhad ...

Publications

Publications Authored by Farhad Ravandi | PubFacts

www.pubfacts.com

Publications Authored by Farhad Ravandi

IJMS | Free Full-Text | Clinical Outcomes and Co-Occurring Mutations...

www.mdpi.com

Farhad Ravandi 1. , Marina Konopleva 1. , Steven Kornblau 1. , Hagop Kantarjian 1. , Kapil Bhalla 1. and Courtney D. DiNardo 1,*. 1. Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX , USA. 2. Department of Hematopathology, The University of Texas MD ...

Publications Authored by Farhad Ravandi-Kashani | PubFacts

www.pubfacts.com

Publications Authored by Farhad Ravandi-Kashani

Video & Audio

A new era for elderly AML patients | VJHemOnc

www.vjhemonc.com

▶ 1:48Here, Farhad Ravandi-Kashani, MD, of the University of Texas MD Anderson Cancer Center, Houston, TX ...

ASH 2016: AML, CLL and leukaemogenesis latest - ecancer

ecancer.org

Dr Farhad Ravandi - MD Anderson Cancer Center, Houston, USA. Dr Ravandi talks to ecancertv about his highlights of ASH

Reports & Statements

(1 - 4 from 9

–show all

)

Google Groups: Fw: Research Focus: New Developments in Acute Myeloid Leukemia

: CME-Certified Module Research Focus: New Developments in Acute Myeloid

Google Groups: Intraday Lounge December 21st 2010

: ... to currently available treatment options," said Farhad Ravandi, MD, Associate

Acute Leukemias Update | Interview With Farhad Ravandi, MD...

player.fm

Conversations with Oncology Investigators. Bridging the Gap between Research and Patient Care. Interview with Farhad Ravandi, MD ...

‎Hematologic Oncology Update: Acute Leukemias Update |...

podcasts.apple.com

Conversations with Oncology Investigators. Bridging the Gap between Research and Patient Care. Interview with Farhad Ravandi, MD conducted by Neil Love, MD....

Miscellaneous

(1 - 20 from 63

–show all

)

BLOCK | PracticeUpdate

www.practiceupdate.com

Current and Emerging Research Areas in AML: Farhad Ravandi, MD. PracticeUpdate Editorial Team. Save Recommend. Share. Facebook ...

Dr. Farhad Ravandi Discusses Vosaroxin in the VALOR Trial

www.onclive.com

Farhad Ravandi, MD, from the University of Texas MD Anderson Cancer Center in Houston, describes results from the phase III VALOR trial that explored vosaroxin...

Dr. Farhad Ravandi on How to Treat Minimal Residual Disease

www.targetedonc.com

Farhad Ravandi, MD, Professor in the Department of Leukemia, MD Anderson Cancer Center‎, discusses minimal residual disease. Ravandi says historically,...

Dr. Farhad Ravandi Kashani, Hematology Oncology, Houston TX

www.topnpi.com

Dr. Farhad Ravandi Kashani in Houston, TX. Dr. Farhad Ravandi Kashani, MD specializes in hematology oncology, practices at Holcombe Boulevard, phone...

Dr. Farhad Ravandi-Kashani NPI ; Houston, TX - DocBios

www.docbios.com

Visit DocBios.com for information about Dr. Farhad Ravandi-Kashani. Find Phone & Address information, specialties, ratings and more

Farhad Ravandi | VJHemOnc

www.vjhemonc.com

Farhad Ravandi. 5:30. Treating acute myeloid leukemia with VALOR – vosaroxin in combination with cytarabine. Farhad Ravandi · 7:52. Phase III trial shows vosaroxin improves overall survival in acute myeloid leukaemia. Farhad Ravandi. VJHemOnc is intended for Healthcare Professionals only. By choosing to continue, ...

NPI Farhad Ravandi-kashani in Houston - Address, Medicare...

npino.com

NPI Farhad Ravandi-kashani in Houston - Practice Location Address, Medicare Status, and Contact Numbers

Acute Leukemias Update | Interview with Farhad Ravandi, MD |...

play.acast.com

Bridging the Gap between Research and Patient Care. Interview with Farhad Ravandi, MD conducted by Neil Love, MD. Produced by Research To Practice.

2015 ASCO Annual Meeting - Oncology - Clinical Care Options

www.clinicaloptions.com

This program provides coverage of the ASCO annual meeting with downloadable slidesets and expert analysis of the most clinically relevant study results....

Farhad Ravandi-Kashani, MD - Oncology Congress :: PROLibraries.com -...

www.prolibraries.com

HM Treatment of APL in 2009: Cures Without Chemotherapy? Speaker: Farhad Ravandi-Kashani, MD (Speaker Disclosure). Format: Synced Audio / Slides.

Pardon Our Interruption

www.practiceupdate.com

Prior to the fourth Annual Meeting of the Society of Hematologic Oncology (SOHO), held in Houston, Texas, September 6-10, 2016, Dr. Farhad ...

Research To Practice | Oncology Videos: Leukemias | Farhad Ravandi, MD

videopodcast.researchtopractice.com

Acute Leukemias Update — Part 2: Our interview with Dr Ravandi highlights the following topics as well as cases from his practice: Impact of ...

Farhad Ravandi-Kashani — MD Anderson Cancer Center

mdanderson.elsevierpure.com

A CpG island methylator phenotype in acute myeloid leukemia independent of IDH mutations and associated with a favorable outcome. Kelly, A. D., Kroeger, H., Yamazaki, J., Taby, R., Neumann, F., Yu, S., Lee, J. T., Patel, B., Li, Y., He, R., Liang, S., Lu, Y., Cesaroni, M., Pierce, S. A., Kornblau, S. M., Bueso-Ramos, C. E., ...

Non-Hodgkin Lymphoma: Ravandi, Farhad - Expertscape.com

www.expertscape.com

Medical and scientific articles about Lymphoma, Non-Hodgkin, written by Farhad Ravandi

2016 Hematology Meeting - Oncology - Clinical Care Options

www.clinicaloptions.com

In this downloadable slideset, Elias Jabbour, MD, and Farhad Ravandi, MD, review key studies and data presented at the American Society of Hematology annual meeting relevant to the management of patients with acute or chronic leukemias. Source: American Society of Hematology Annual Meeting.

Cladribine and Rituximab in Treating Patients With Hairy Cell...

clinicaltrials.gov

Contact: Farhad Ravandi-Kashani, MD, Locations. United States, Texas. University of Texas MD Anderson Cancer Center ... Principal Investigator: Farhad Ravandi-Kashani, MD, M.D. Anderson Cancer Center. More Information. Go to sections. Study Description Study Design Arms and Interventions Outcome ...

Dr. Ravandi on Targeting CD33 in Relapsed/Refractory AML

www.onclive.com

Farhad Ravandi, MBBS, professor of medicine, department of leukemia, The University of Texas MD Anderson Cancer Center, discusses targeting CD33 in patients...

A pilot study of imatinib, low-dose cytarabine and idarubicin for...

www.scholars.northwestern.edu

A pilot study of imatinib, low-dose cytarabine and idarubicin for patients with chronic myeloid leukemia in myeloid blast phase. Alfonso Quintás-Cardama, Hagop Kantarjian, Guillermo Garcia-Manero, Susan O'Brien, Stefan Faderl, Farhad Ravandi, Francis Giles, Deborah Thomas, William Wierda, Jorge Cortes. Medicine ...

Acute Myeloid Leukemia, Version , NCCN Clinical Practice...

jnccn.org

Farhad Ravandi, MD‡. The University of Texas MD Anderson Cancer Center. Paul J. Shami, MD‡. Huntsman Cancer Institute at the University of Utah. Richard M. Stone, MD‡†. Dana-Farber/Brigham and Women's Cancer Center. Stephen A. Strickland, MD, MSCI‡. Vanderbilt-Ingram Cancer Center. Eunice S. Wang, MD‡.